13F

Stock

Kairos Pharma, LTD.

KAPA · held by 11 managers

Reported value

$329.5K

Holders

11

+2 new · −6 exited

Holders’ est. mark

−$29.5K

Price effect on 7 books still in the name

Largest holder

$129.6K

VANGUARD CAPITAL MANAGEMENT LLC

Notable conviction

Share of each notable manager’s 13F book.

Holder count by quarter

Who holds it

Notable only
InvestorSharesValueEst. markChange
VANGUARD CAPITAL MANAGEMENT LLC231.9K$129.6KHeld
GEODE CAPITAL MANAGEMENT, LLC111.3K$62.2K−$11KAdded$10.5K
VANGUARD FIDUCIARY TRUST CO63.9K$35.7KHeld
SevenBridge Financial Group, LLC44.3K$30.3K−$1.56KCut−$1.55K
Aptus Capital Advisors, LLC44.3K$24.8K−$6.69KCut−$6.69K
TWO SIGMA INVESTMENTS, LP39.5K$22.1K−$5.97KCut−$44.6K
State Street24.1K$13.5K−$3.64KCut−$3.64K
TWO SIGMA SECURITIES, LLC16.2K$9.08KNew
Tower Research Capital LLC (TRC)3.96K$2.21K−$598Cut−$786
HRT FINANCIAL LP21.6K$12−$3Cut−$3
CITIGROUP INC10$6New

Who left

Positions as of Q1 2026. 13F filings arrive up to 45 days after quarter-end and omit shorts. Values are quarter-end marks, as filed. Estimated mark is the price effect on shares still held — not realized P&L or investment advice.